19826132

Source:http://linkedlifedata.com/resource/pubmed/id/19826132

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0011015, umls-concept:C0013216, umls-concept:C0020789, umls-concept:C0023467, umls-concept:C0026259, umls-concept:C0205263, umls-concept:C0441833, umls-concept:C1516985, umls-concept:C2603343
pubmed:issue	32
pubmed:dateCreated	2009-11-9
pubmed:abstractText	To compare the antitumor efficacy of three different anthracyclines in combination with cytarabine and etoposide in adult patients with newly diagnosed acute myeloid leukemia (AML).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/2U10-CA11488-36, http://linkedlifedata.com/resource/pubmed/grant/CA11488-23
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19826132
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Idarubicin, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1527-7755
pubmed:author	pubmed-author:AmadoriSergioS, pubmed-author:BailaLilianaL, pubmed-author:Di RaimondoFrancescoF, pubmed-author:FaziPaolaP, pubmed-author:FerraraFelicettoF, pubmed-author:LabarBorisB, pubmed-author:LisoVincenzoV, pubmed-author:MandelliFrancoF, pubmed-author:MarieJean-PierreJP, pubmed-author:MarmontFilippoF, pubmed-author:MeloniGiovannaG, pubmed-author:MuusPetraP, pubmed-author:PettiMaria-ConcettaMC, pubmed-author:StasiRobertoR, pubmed-author:SuciuStefanS, pubmed-author:ThomasXavierX, pubmed-author:VignettiMarcoM, pubmed-author:WillemzeRoelR, pubmed-author:ZittounRobertR, pubmed-author:de WitteTheoT
pubmed:issnType	Electronic
pubmed:day	10
pubmed:volume	27
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5397-403
pubmed:dateRevised	2010-11-11
pubmed:meshHeading	pubmed-meshheading:19826132-Acute Disease, pubmed-meshheading:19826132-Adolescent, pubmed-meshheading:19826132-Adult, pubmed-meshheading:19826132-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19826132-Cytarabine, pubmed-meshheading:19826132-Daunorubicin, pubmed-meshheading:19826132-Etoposide, pubmed-meshheading:19826132-Female, pubmed-meshheading:19826132-Humans, pubmed-meshheading:19826132-Idarubicin, pubmed-meshheading:19826132-Leukemia, Myeloid, pubmed-meshheading:19826132-Male, pubmed-meshheading:19826132-Middle Aged, pubmed-meshheading:19826132-Mitoxantrone, pubmed-meshheading:19826132-Remission Induction, pubmed-meshheading:19826132-Survival Analysis, pubmed-meshheading:19826132-Survival Rate, pubmed-meshheading:19826132-Treatment Outcome, pubmed-meshheading:19826132-Young Adult
pubmed:year	2009
pubmed:articleTitle	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.
pubmed:affiliation	Department of Cellular Biotechnologies and Hematology, SapienzaUniversity, Rome, Italy.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III, Research Support, N.I.H., Extramural